InspireMD (NSPR) Common Equity (2010 - 2025)

InspireMD has reported Common Equity for 16 years, with the latest figure at $55.2 million in Q4 2025.

• For the quarter ending Q4 2025, Common Equity rose 52.97% year-over-year to $55.2 million; the trailing twelve-month figure through Dec 2025 stood at $55.2 million (up 52.97% YoY), and the FY2025 full-year result was $55.2 million, up 52.97% from the prior year.
• Common Equity for Q4 2025 stood at $55.2 million, down from $64.1 million in the prior quarter.
• The five-year high for Common Equity was $64.1 million in Q3 2025, with the low at $13.4 million in Q1 2023.
• Historically, Common Equity has averaged $36.0 million across 5 years, with a median of $36.6 million in 2021.
• Annual changes were most pronounced in 2021 — Common Equity surged 1164.14% — and 2025, when it slumped 56.71%.
• InspireMD's Common Equity stood at $33.5 million in 2021, then slumped by 48.13% to $17.4 million in 2022, then soared by 127.11% to $39.5 million in 2023, then declined by 8.65% to $36.1 million in 2024, then surged by 52.97% to $55.2 million in 2025.
• The last three Common Equity figures came in at $55.2 million (Q4 2025), $64.1 million (Q3 2025), and $20.2 million (Q2 2025), per Business Quant data.